Back
Expedia Group Vs. Mirum Pharmaceuticals Industry Stock Comparison
Buy
74
EXPE
Expedia Group
Last Price:
142.52
Seasonality Move:
4.68%
Sell
40
MIRM
Mirum Pharmaceuticals
Last Price:
39.35
Seasonality Move:
5.99%
Buy
74
Expedia Group (EXPE)
is a Buy
Is Expedia Group a Buy, Sell or Hold?
- The current Expedia Group [EXPE] share price is $139.70. The Score for EXPE is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- EXPE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Mirum Pharmaceuticals (MIRM)
is a Sell
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $37.93. The Score for MIRM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- MIRM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $139.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXPE is experiencing slight buying pressure.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $37.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight selling pressure.
EXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.64 | Buy |
| Relative Strength Index (14 RSI): | 60.84 | Buy |
| Chaikin Money Flow: | 475477 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (131.73 - 138.53) | Buy |
| Bollinger Bands (100): | (116.62 - 134.94) | Buy |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 36.81 | Sell |
| Chaikin Money Flow: | -512602 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.29 - 42.71) | Sell |
| Bollinger Bands (100): | (27.1 - 41.32) | Buy |
EXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 134.46 | Buy |
| 20-day SMA: | 135.84 | Buy |
| 50-day SMA: | 131.23 | Buy |
| 200-day SMA: | 133.47 | Buy |
| 8-day EMA: | 136.08 | Buy |
| 20-day EMA: | 134.59 | Buy |
| 50-day EMA: | 131.58 | Buy |
| 200-day EMA: | 127.71 | Buy |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.68 | Sell |
| 20-day SMA: | 41.55 | Sell |
| 50-day SMA: | 40.65 | Sell |
| 200-day SMA: | 31.03 | Buy |
| 8-day EMA: | 40.34 | Sell |
| 20-day EMA: | 40.95 | Sell |
| 50-day EMA: | 39.41 | Sell |
| 200-day EMA: | 32.8 | Buy |
Expedia Group Earnings Growth & EXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.13 per share, an increase next quarter of $1.06 per share, an increase this year of $2.07 per share, and an increase next year of $2.51 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.
Expedia Group Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||